[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351947-105":59,"doc-detail-351947-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinical-phenotypes-of-uveal-melanoma-in-patients-with-germline-pathogeniclikely-pathogenic-bap1-variants","Clinical phenotypes of uveal melanoma in patients with germline pathogenic/likely pathogenic BAP1 variants","","Germline pathogenic or likely pathogenic variants (GPVs) in BRCA-1 Associated Protein 1 (BAP1) are linked to a spectrum of tumors, including uveal melanoma (UM). This study analyzed the clinical phenotype of 29 UM patients with BAP1 GPVs and performed a systematic literature review. Patients with BAP1 GPVs showed a significantly lower median age of diagnosis than SEER-reported UM. Metastatic risk and overall survival differed significantly from class 1 tumors but were similar to class 2. In radiation-treated cases (n=12), no secondary cancers occurred in the radiation field over a median 26.5 months follow-up (range 4–119), though one patient developed UM growth at a distinct site in the same eye.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-phenotypes-of-uveal-melanoma-in-patients-with-germline-pathogeniclikely-pathogenic-bap1-variants/351947/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-phenotypes-of-uveal-melanoma-in-patients-with-germline-pathogeniclikely-pathogenic-bap1-variants/351947.png","ImageObject",300,407,{"name":92,"@type":93},"Blitz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study on BAP1 GPVs in uveal melanoma patients?","Question",{"text":112,"@type":113},"To characterize the clinical phenotypes and outcomes of a cohort of 29 UM patients with germline BAP1 pathogenic/likely pathogenic variants, and to support the findings with a systematic review of the literature.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did diagnosis age in UM patients with BAP1 GPVs compare with SEER-reported UM?",{"text":117,"@type":113},"UM patients with BAP1 GPVs had a significantly lower median age of diagnosis than the median age reported for UM patients in the SEER database.",{"name":119,"@type":110,"acceptedAnswer":120},"What survival and metastatic risk patterns were observed relative to tumor classes?",{"text":121,"@type":113},"Metastatic risk and overall survival were statistically significant compared with class 1 tumors, but were comparable to those observed in UM patients with class 2 tumors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351947,1790167392,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","medRxiv preprint doi: [https://doi.org/10.64898/2026.06.29.26356877](https://doi.org/10.64898/2026.06.29.26356877); this version posted July 1, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-ND 4.0 International license .  \nClinical phenotypes of uveal melanoma in patients with germline  \npathogenic/likely pathogenic BAP1 variants.  \nReham Abdalla 1 , 2 , Olivia B. Taylor1 , Joseph McElroy3 , Kaylee Ramsey 1 , Lindsey Byrne4 , Abdelrahman M. Elsayed 1 , Colleen M. Cebulla 1 , Mohamed H. Abdel-Rahman1,5*  \n1 Department of Ophthalmology and Visual Sciences, Havener Eye Institute, The Ohio State University Wexner Medical Center, Columbus, (OH), USA  \n2 Department of Ophthalmology, Faculty of Medicine , Assiut University, Assiut , Egypt  \n3 Center for Biostatistics, Department of Biomedical Informatics, College of Medicine, The Ohio State University  \n4 Division of Human Genetics, Department of Internal Medicine, The Ohio State University Columbus, Columbus, OH, USA.  \n5 The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.  \n*Corresponding author: Mohamed H Abdel-Rahman, MD, PhD; 400 W 12th Ave, 225 Wiseman Hall, Columbus, Ohio 43210; [Mohamed.abdel-rahman@osumc.edu](Mohamed.abdel-rahman@osumc.edu)  \nAbstract  \nGermline pathogenic or likely pathogenic variants (GPVs) in BRCA-1 Associated Protein 1 (BAP1 ) are associated with a spectrum of tumors, including uveal melanoma (UM) . Currently, UM patients with BAP1 GPVs are treated as high-risk class 2 tumors based on mostly empiric data. In the current study, we examined the clinical phenotype of a cohort of 29 UM patients with BAP1 GPVs. We also carried out a systematic review of the literature of UM patients with BAP1 GPVs. We observed that UM patients with BAP1 GPVs have significantly lower median age of diagnosis compared to median age reported in UM patients in the Surveillance, Epidemiology, and End Results Program (SEERS) database. Metastatic risk and overall survival in the UM BAP1 GPVs cohort were statistically significant from those in patients with class 1 tumors, but were comparable to those observed in UM patients with class 2 tumors. In UM BAP1 GPVs treated with radiation (n= 12) , no secondary cancers were observed in the field of radiation in a median 26.5 months (range, 4–119 months) follow up period. One patient experienced a separate growth of UM at a distinct location within the same eye. These data support managing UM in patients with BAP1 GPVs as aggressive class 2 tumors, following the currently established standard of care for these high-risk tumors.  \nKey Points  \n• A small percent of uveal melanomas is attributed to inherited (germline) pathogenic variants in the BAP1 gene. The clinical outcome of these patients is unclear.  \nNOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.  \nmedRxiv preprint doi: [https://doi.org/10.64898/2026.06.29.26356877](https://doi.org/10.64898/2026.06.29.26356877); this version posted July 1, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-ND 4.0 International license .  \n• We studied clinical characteristics, secondary tumors and survival outcomes of uveal melanoma patients with germline BAP1 pathogenic variants.  \n• Uveal melanoma patients with germline BAP1 pathogenic variants were more likely to be diagnosed earlier and their survival outcomes were poorer than those with class 1 tumors, but similar to those with class 2 tumors. In patients treated with radiation, no secondary malignancies were observed but one UM patien","cbCaiqS50trGQKN6","https://ap.wps.com/l/cbCaiqS50trGQKN6","pdf",1327370,18,"English","# Abstract\n# Key Points\n# Introduction","[{\"question\":\"What was the main objective of the study on BAP1 GPVs in uveal melanoma patients?\",\"answer\":\"To characterize the clinical phenotypes and outcomes of a cohort of 29 UM patients with germline BAP1 pathogenic/likely pathogenic variants, and to support the findings with a systematic review of the literature.\"},{\"question\":\"How did diagnosis age in UM patients with BAP1 GPVs compare with SEER-reported UM?\",\"answer\":\"UM patients with BAP1 GPVs had a significantly lower median age of diagnosis than the median age reported for UM patients in the SEER database.\"},{\"question\":\"What survival and metastatic risk patterns were observed relative to tumor classes?\",\"answer\":\"Metastatic risk and overall survival were statistically significant compared with class 1 tumors, but were comparable to those observed in UM patients with class 2 tumors.\"}]","Clinical phenotypes of uveal melanoma in patients with germline pathogenic/likely pathogenic BAP1 variants | PDF",1790096577,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5296667ed1202e6acf9c1963b3b9a39a.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d037658472c2c048d2c9dcc4b383f1d.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7f64b113a02edf6fc09622068ab6ddd.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/236a9c89e2d401f754285a854a41f4e2.webp",980,1268]